| Lenalidomide |
ENSG00000088970.11 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000131484.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000149656.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000163597.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000166770.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000170590.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000170590.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000172965.10 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000174171.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000174680.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000175147.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000175701.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000175772.10 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000177337.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000177757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000177788.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000177993.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000178412.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000178803.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000178947.8 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000180279.5 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000180712.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000181800.5 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000182165.13 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000182366.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000182376.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000182873.4 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000184068.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000184324.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000185186.4 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000185904.7 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000188365.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000188825.9 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000189229.10 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000196295.7 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000196295.7 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000196756.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000197291.4 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000197558.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000203288.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000203288.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000203588.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000203588.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000203801.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000204055.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000204791.4 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000204792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000204792.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000204832.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000204934.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000204949.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000205037.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000205054.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000205181.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000205488.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000205500.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000205628.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000205634.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000205885.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000206028.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000206567.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000212163.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000212163.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000213468.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000214293.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000214401.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000214559.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000214725.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000214803.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000215374.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000215394.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000215483.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000215841.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000215866.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000217258.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000217258.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000219665.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000220161.4 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000222041.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000222044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000223396.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000223462.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000223478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000223523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000223579.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000223660.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000223804.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000223813.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000223839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000223855.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000223882.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000223891.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000224032.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224043.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000224078.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000224081.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000224167.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224173.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000224424.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000224429.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224468.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000224511.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000224596.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224597.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000224614.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000224623.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000224638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000224666.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000224691.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000224699.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224707.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000224738.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000224738.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224745.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224794.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000224799.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224817.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000224855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000224863.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000224875.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000224897.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000224930.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000224934.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000224950.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000224977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000224977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000224977.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000224992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000225028.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000225205.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000225210.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000225269.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000225331.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000225335.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000225411.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000225434.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000225472.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000225532.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000225532.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000225703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000225703.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000225751.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000225761.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000225778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000225783.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000225798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000225889.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000225891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000225948.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000225952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000225963.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000226125.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000226134.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000226167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000226194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000226263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000226291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000226352.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000226381.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000226445.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000226476.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000226609.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000226629.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000226669.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000226782.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000226797.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000226816.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000226852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000226856.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000226864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000226869.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000226876.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000226954.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000227014.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000227014.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000227017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227036.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000227036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227068.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000227071.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000227071.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000227083.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000227115.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000227116.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000227155.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000227155.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000227155.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000227161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227354.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000227359.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000227400.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000227400.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227403.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000227409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227456.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000227477.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000227484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227495.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000227496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000227512.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000227533.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000227543.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000227598.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000227603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000227617.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000227627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000227704.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000227953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000228037.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228037.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000228063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000228086.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000228107.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000228135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000228140.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000228141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000228201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228274.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000228290.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000228293.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000228294.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228323.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000228340.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000228369.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000228372.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228444.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000228452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000228481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228487.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000228561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000228596.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000228624.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000228624.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000228649.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000228661.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000228682.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000228686.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000228718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000228742.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000228775.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000228786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000228786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000228826.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000228889.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000228972.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000229017.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000229036.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000229122.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000229124.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000229154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000229196.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000229214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000229330.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000229368.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000229498.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000229558.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000229589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229611.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229666.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000229666.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229692.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000229697.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000229727.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000229739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000229780.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000229832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000229839.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000229841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000229891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000229912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000229950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000229951.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000229956.5 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000229967.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000229999.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000230010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000230010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000230046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000230074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000230082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000230084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000230148.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000230155.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000230177.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000230184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000230184.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000230289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000230319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000230368.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000230410.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000230423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000230454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000230498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000230506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000230537.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000230539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000230561.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000230613.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000230615.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000230615.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000230633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000230724.5 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000230725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000230735.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000230736.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000230751.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000230753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000230839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000230912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000230939.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000231025.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000231050.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000231057.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000231057.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000231073.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000231104.4 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000231119.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000231172.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000231196.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000231233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231249.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231310.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000231346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231473.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000231483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000231521.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000231527.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000231528.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000231566.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000231595.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000231709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000231709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000231731.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000231734.4 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000231760.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000231769.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000231794.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000231795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231806.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231816.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231871.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000231881.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000231948.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000231993.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000232019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000232117.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000232118.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000232192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000232229.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000232300.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000232352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000232406.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000232455.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000232455.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000232520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000232564.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000232564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000232611.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000232618.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000232623.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000232640.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000232642.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000232656.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000232725.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000232725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000232739.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000232762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000232788.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000232855.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000232907.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000232912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000232931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000232934.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000232973.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000233006.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000233044.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000233117.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000233143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000233154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000233220.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000233223.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000233244.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000233308.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000233427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000233452.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000233496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000233515.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000233554.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000233613.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000233621.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000233635.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000233672.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000233694.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000233757.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000233797.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000233799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000233800.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000233845.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000233847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000233851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000233854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000233901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000233901.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000233903.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000233922.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000234006.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000234019.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000234084.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000234147.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000234183.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000234199.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000234206.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000234225.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000234233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000234281.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000234292.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000234323.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000234362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000234449.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000234492.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000234617.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000234663.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000234665.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000234678.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000234707.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000234779.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000234793.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000234840.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000234869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000234869.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000234871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000234912.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000234913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000234936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000234936.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000234943.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000234943.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000235007.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000235027.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000235052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000235072.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000235085.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000235126.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000235131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000235204.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000235244.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000235246.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000235262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000235269.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000235326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000235381.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000235387.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000235387.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000235426.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000235495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000235530.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000235565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000235609.4 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000235629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000235635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000235688.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000235703.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000235706.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000235724.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000235760.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000235781.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000235795.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000235820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000235820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000235831.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000235910.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000235927.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000235958.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000235989.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000236016.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000236016.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000236031.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000236051.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000236065.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000236065.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000236098.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000236107.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000236194.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000236200.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000236209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000236269.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000236364.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000236377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000236426.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000236434.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000236438.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000236545.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000236548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000236711.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000236714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000236799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000236799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000236871.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000236889.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000236924.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000236947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000236947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000236983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000237036.4 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000237073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000237152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000237253.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000237301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000237356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000237359.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000237380.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000237404.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000237481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000237491.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000237513.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000237531.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000237543.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000237581.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000237637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000237689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000237689.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000237721.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000237737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000237807.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000237813.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000237852.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000237857.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000237883.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000237892.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000237903.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000237943.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000237943.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000237945.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000237976.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000238018.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000238019.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000238035.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000238043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000238280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000239300.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000239353.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000239453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000239480.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000239552.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000239608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000239664.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000239828.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000239906.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000240207.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000240207.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000240423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000240453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000240453.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000240571.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000240591.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000240875.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000240922.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000241135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000241269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000241288.3 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000241288.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000241570.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000241954.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000241985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000241990.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000242094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000242104.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000242104.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000242357.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000242659.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000242808.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000242861.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000243415.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000243479.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000244036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000244036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000244161.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000244198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000244268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000244310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000244380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000244380.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000244513.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000244586.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000244625.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000244791.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000244945.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000244998.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000245112.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000245146.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000245248.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000245330.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000245750.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000245812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000245928.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000246016.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000246067.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000246089.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000246174.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000246174.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000246225.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000246273.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000246334.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000246339.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000246422.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000246422.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000246526.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000246627.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000246640.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000246731.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000246740.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000246792.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000246859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000246898.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000247081.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000247092.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000247095.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000247157.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000247311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000247317.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000247324.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000247324.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000247416.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000247595.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000247675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000247853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000247877.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000247877.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000248027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000248027.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000248079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000248079.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000248100.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000248103.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000248115.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000248240.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000248243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000248268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000248275.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000248309.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000248356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000248367.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000248399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000248473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000248647.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000248664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000248698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000248758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000248774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000248890.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000248925.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000248936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000248973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000249028.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000249084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000249112.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000249249.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000249307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000249307.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000249356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000249359.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000249359.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000249364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000249395.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000249407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000249417.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000249476.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000249476.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000249494.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000249509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000249593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000249609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000249610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000249637.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000249641.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000249731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000249753.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000249781.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000249787.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000249790.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000249846.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000249870.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000249896.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000249898.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000249996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000250027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000250039.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000250049.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000250122.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000250133.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000250198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000250267.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000250274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000250320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000250413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000250451.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000250582.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000250608.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000250614.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000250682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000250682.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000250742.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000250751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000250765.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000250874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000250899.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000250900.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000250993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000251002.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000251026.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000251072.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000251301.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000251307.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000251370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000251370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000251432.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000251455.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000251460.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000251513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000251513.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000251556.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000251603.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000251615.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253121.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253133.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000253308.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000253372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000253374.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000253390.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253395.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000253408.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000253530.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000253552.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000253553.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000253659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000253669.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000253688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000253704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000253706.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000253736.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000253744.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000253819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000253844.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253844.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000253853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000253854.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000253859.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000253893.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000253944.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000253961.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000253965.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000254084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000254144.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000254165.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000254231.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000254233.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000254248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000254315.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000254319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000254341.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000254343.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000254353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000254433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000254473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000254480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000254484.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000254495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000254560.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000254592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000254606.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000254610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000254610.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000254615.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000254620.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000254631.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000254676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000254791.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000254847.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000254865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000254900.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000254972.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000254985.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000255008.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000255052.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000255100.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000255145.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000255165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000255274.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000255276.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000255306.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000255310.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000255310.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000255337.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000255355.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000255364.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000255421.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000255455.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000255458.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000255467.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000255471.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000255487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000255487.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000255507.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000255509.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000255565.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000255571.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000255621.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000255651.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000255669.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000255672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000255693.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000255723.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000255775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000255843.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000255933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000255989.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000256006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000256020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000256050.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000256115.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000256151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000256237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000256250.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000256442.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000256448.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000256458.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000256481.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000256540.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000256546.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000256747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000256984.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000257058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000257105.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000257139.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000257261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000257366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000257381.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000257391.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000257488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000257527.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000257527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000257563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000257563.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000257636.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000257702.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000257718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000257769.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000257924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000257924.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000257931.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000258034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000258096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000258172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000258172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000258199.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000258203.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000258302.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000258303.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000258303.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000258317.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000258323.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000258334.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258378.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000258378.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000258424.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258449.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000258450.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000258479.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000258525.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000258545.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000258545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258646.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258673.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000258701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000258704.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000258725.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000258733.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000258736.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258777.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000258793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000258813.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000258891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258897.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000258902.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258942.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000258943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000258946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258957.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000258976.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000258983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000259002.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000259036.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000259070.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000259088.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000259146.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000259178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000259182.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000259209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000259212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259215.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000259240.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259250.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000259264.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000259298.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000259319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000259341.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000259343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000259345.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000259349.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000259359.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000259366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259380.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000259398.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000259416.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000259417.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259418.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000259426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259437.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000259450.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259463.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000259483.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000259514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000259536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259536.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000259590.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259606.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259644.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259656.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000259673.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000259711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000259715.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000259719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000259736.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000259772.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000259797.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000259806.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259807.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000259840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000259854.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000259863.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000259876.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000259886.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000259935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000259994.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260005.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000260035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000260063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000260077.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000260118.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000260160.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000260171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260177.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260213.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260277.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000260285.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000260285.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260351.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000260352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000260360.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000260396.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000260400.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000260422.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000260423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000260439.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000260468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260475.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000260498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000260515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000260528.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000260536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000260563.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000260577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260579.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000260588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000260619.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000260625.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000260645.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260646.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000260646.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000260661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260750.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000260757.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260790.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000260796.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260814.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000260814.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000260831.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000260855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000260910.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000260923.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000260936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000260941.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000260948.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000260955.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000260977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000260996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000261024.2 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000261051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261051.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000261055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000261068.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000261069.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261126.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000261135.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000261140.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000261172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000261172.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000261191.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000261220.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000261266.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000261286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000261288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261288.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000261295.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000261360.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000261396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261420.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000261460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261462.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000261474.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000261481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000261485.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000261544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000261560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000261578.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000261578.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000261582.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000261584.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000261613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000261669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000261685.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000261692.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000261693.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000261697.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000261737.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000261757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000261770.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000261777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000261799.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000261823.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000261864.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000261889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262074.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000262115.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000262136.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000262152.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000262155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000262155.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000262185.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000262222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262265.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000262296.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000262319.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000262372.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000262380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262434.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000262580.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000262652.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000262662.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000262686.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000262692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000262772.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000262772.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000262777.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000262873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262877.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262888.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000262973.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000262979.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000262999.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000263080.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000263096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000263272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000263293.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000263316.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000263325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000263443.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000263466.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000263531.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000263531.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000263624.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000263627.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000263680.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000263683.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000263874.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000263924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000264026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000264107.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000264235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000264269.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000264513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000264569.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000264575.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000264630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000264673.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000264859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000265142.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000265242.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000265511.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000265511.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000265625.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000265666.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000265728.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000265728.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000265749.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000265800.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000265845.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000265908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000265912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000266111.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000266126.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000266304.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000266385.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000266445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000266601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000266604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000266677.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000266801.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000266869.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000266900.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000266904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000266942.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000266942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000266965.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000266965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000266969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000266975.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000266975.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000266993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000266999.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000267024.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000267040.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000267064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000267073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000267082.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000267093.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000267115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000267117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000267117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000267128.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000267131.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000267174.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267197.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000267255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000267255.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000267298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267325.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000267327.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000267383.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000267405.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267405.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000267414.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000267419.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267474.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267476.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000267481.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000267498.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000267498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000267551.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000267560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000267567.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000267581.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000267586.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000267613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000267667.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000267667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000267682.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000267747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000267747.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000267758.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267787.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000267852.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000267852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000267924.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000267943.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000268051.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000268066.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000268093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000268186.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000268204.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000268289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000268340.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000268340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000268340.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000268516.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000268568.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000268583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000268605.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000268615.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000268655.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000268894.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000268895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000268912.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000269082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000269161.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000269293.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000269425.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000269463.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000269481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000269534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000269560.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000269574.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000269688.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000269696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000269696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000269806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000269893.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000269895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000269898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000269899.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000269901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000269903.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000269918.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000269921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000269921.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000269951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000269983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000270000.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000270006.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000270010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000270062.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000270100.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000270100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000270103.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000270117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000270117.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000270124.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000270164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000270168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000270168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000270168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000270174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000270223.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000270246.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000270246.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000270332.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000270346.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000270346.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000270346.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000270462.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000270487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000270557.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000270562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000270571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000270599.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000270604.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000270704.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000270755.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000270761.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000270876.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000270951.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000271109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000271147.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000271204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000271204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000271270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000271270.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000271344.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000271401.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000271420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000271420.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271430.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271643.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000271732.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000271742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000271743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000271757.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271771.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000271778.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000271778.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000271789.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271803.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000271855.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000271911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000271913.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000271927.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000271963.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271973.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000271973.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000271992.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000271996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000271998.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000272010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272053.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272070.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000272070.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000272088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272088.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000272137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000272138.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000272140.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000272141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000272142.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000272142.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000272146.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000272158.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000272183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000272198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272209.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000272219.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000272219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272254.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000272254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272343.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000272365.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000272368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000272369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000272375.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000272377.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000272403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000272417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272420.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000272426.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000272449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272459.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272489.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000272519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272524.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000272549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272551.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000272556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000272556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272567.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272691.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000272735.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000272754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000272769.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000272782.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000272791.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000272795.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000272815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000272824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000272828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000272846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000272892.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000272892.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Lenalidomide |
ENSG00000272905.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000272913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000272915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000272966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000272970.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273002.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000273018.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000273035.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000273038.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000273058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000273077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000273123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273139.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000273175.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000273188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000273218.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Lenalidomide |
ENSG00000273230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000273233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Lenalidomide |
ENSG00000273257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273265.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Lenalidomide |
ENSG00000273281.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Lenalidomide |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273295.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000273309.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Lenalidomide |
ENSG00000273319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Lenalidomide |
ENSG00000273319.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Lenalidomide |
ENSG00000273342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Lenalidomide |
ENSG00000273381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Lenalidomide |
ENSG00000273381.1 |
Predicted lncRNA |
Sarcoma |
|
| Lenalidomide |
ENSG00000273403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Lenalidomide |
ENSG00000273406.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Lenalidomide |
ENSG00000273464.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Lenalidomide |
ENSG00000273472.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|